# Human Serum Albumin Affinity for Putrescine Using ITC and STD-NMR

## TL;DR

This study shows that putrescine, a toxin linked to kidney disease, binds weakly to human serum albumin, challenging earlier assumptions and highlighting the need for better measurement methods.

## Contribution

The study provides new evidence that putrescine has weak and non-specific binding to HSA using more accurate techniques like ITC and STD-NMR.

## Key findings

- Putrescine interacts weakly and non-specifically with human serum albumin.
- Earlier methods like UV–visible and fluorescence may overestimate binding strength.
- Putrescine may preferentially bind to other plasma proteins, contributing to CKD progression.

## Abstract

Understanding the binding interactions between protein-bound uremic toxins (PBUTs) and human serum albumin (HSA) is critical for advancing treatments for chronic kidney disease (CKD). While previous studies have suggested that putrescine, a diamine PBUT, exhibits moderate binding affinity to HSA, this study provides evidence of the contrary. Using isothermal titration calorimetry and saturation transfer difference nuclear magnetic resonance , we demonstrate that putrescine’s interaction with HSA is weak, non-specific, and thermodynamically negligible in the range of conditions studied. Unlike earlier studies relying on spectroscopy techniques such as UV–visible absorption and fluorescence, which may overestimate binding strength, the results presented here highlight the limitations of indirect methodologies and underscore the importance of more sensitive approaches for accurate energy characterization. Our findings suggest that putrescine only weakly interacts non-specifically with HSA and may bind more preferentially to other plasma proteins, contributing to its accumulation in CKD patients.